RTX (NYSE:RTX) announced Tuesday that its Raytheon business has been awarded a $1.7 billion foreign military sales contract to deliver four Patriot® air and missile defense systems to Spain.
Agenus (NASDAQ:AGEN) has published peer-reviewed results from the ovarian cancer cohort of its Phase 1b trial in The Journal for ImmunoTherapy of Cancer (JITC), highlighting a potential breakthrough for a patient population with historically limited options.
Cipher Mining (NASDAQ:CIFR) has acquired a 200-megawatt development site in Ohio, marking its first major expansion outside of Texas as it pivots toward high-performance computing (HPC) and AI hosting.
Coya Therapeutics, (NASDAQ: COYA) announced today that Health Canada has accepted its Clinical Trial Application (CTA) for COYA 302, a potential breakthrough combination biologic for the treatment of Amyotrophic Lateral Sclerosis (ALS).
New Era Energy & Digital (NASDAQ:NUAI) has entered into a binding agreement to acquire the remaining 50% ownership interest in Texas Critical Data Centers LLC (TCDC) from Sharon AI, the company announced Tuesday.
Dyne Therapeutics (NASDAQ:DYN) announced the appointment of Vikram Karnani to its Board of Directors on December 23, 2025.
VSE Corporation (NASDAQ:VSEC) has finalized its acquisition of Aero 3, a global leader in the maintenance, repair, and overhaul (MRO) of commercial aircraft wheels and brakes.
Zai Lab Limited (NASDAQ:ZLAB) received marketing authorization from China’s National Medical Products Administration (NMPA) for Cobenfy, a groundbreaking treatment for schizophrenia in adults.
Trinity Biotech (NASDAQ:TRIB) shares are in focus after the diagnostics specialist reported a return to positive adjusted EBITDA and secured a major 9 million-unit order for its flagship HIV screening product.
Invivyd (NASDAQ:IVVD) received U.S. Food and Drug Administration Fast Track designation for VYD2311, an investigational monoclonal antibody designed as a long-acting, intramuscular alternative to traditional vaccines for individuals at high risk of severe COVID-19.
AtaiBeckley (NASDAQ:ATAI) saw its common stock added to the NASDAQ Biotechnology Index (NBI) prior to the market open on Dec. 22, 2025, marking a significant milestone in the company’s evolution as a leader in neuropsychiatric drug development.
Jeffs' Brands (NASDAQ:JFBR) is undergoing a radical corporate transformation, moving away from its traditional Amazon marketplace business to focus on the homeland security and advanced technology sectors.
